arrow
BackJournal Details
P

psoriasis: targets and therapy

IF
Papers17
Citations
Journal Papers 22
Publication Date
Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis
delete2026-05-25
delete0
deleteOAAI
deleteYingyuan Yu; Bingjie Li; Yu Wang; Zhengkai Qu; Xin Wang; Yuxiong Jiang; Xiaoyuan Zhong; Youdong Chen; Dawei Huang; Xinling Bi; Jiajing Lu; Yangfeng Ding; Yu Gong; Jun Gu; Xilin Zhang; Yuling Shi
deleteShare
deleteSave
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE Study
delete2026-05-12
delete0
deleteOAAI
deleteUlrich Mrowietz; Rachel Sommer; Ziad Reguiai; Sascha Gerdes; Esteban Daudén; Wolfgang Weger; Julia-Tatjana Maul; Luigi Naldi; Pierre-Dominique Ghislain; Philip M Laws; Elke MGJ De Jong; Sicily Mburu; Volker Koscielny; Eric Massana; Victor Sapena; Arnau Domenech; Ismail Kasujee; Matthias Augustin
deleteShare
deleteSave
Application of Trichoscopy and Novel Non-Invasive Imaging Techniques in the Diagnosis and Management of Patients with Scalp Psoriasis
delete2026-03-30
delete0
deleteOAAI
deleteAleksandra Kuchnicka, Urszula Fałkowska, Piotr Konopelski, Aleksandra Anderson, Adriana Rakowska, Marta Kurzeja, Małgorzata Olszewska, Lidia Rudnicka
deleteShare
deleteSave
Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A
delete2026-03-27
delete0
deleteOAAI
deleteZhen Meng; Jieru Ren; Yuhsien Lai; Siyao Lu; Huiyan Wu; Yanyun Jiang; Zhan Zhang; Guozhen Tan; Zhenrui Shi
deleteShare
deleteSave
The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis
delete2026-02-16
delete0
deleteOAAI
deleteYanhua Liang; Baoqing Deng; Epipode Ntawuyamara; Hervé Bachelez; Fuxi Wang; Hao Zhang; Zhenying Zhang; Zhengfeng Li; Lin Dang; Yajie Wang; Xianbiao Zou; Li Wang; Dejian Duan; Hongxiang Chen; Wenjun Zheng; Hui Huang; Min Zhang; Qingxian Cai; Ye Chen; Yingli Zhang; Zeyuan Lu; Yalin Ren; Jinxian Huang
deleteShare
deleteSave
Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan
delete2026-02-11
delete0
deleteOAAI
deleteYouran Xu; Tong Li; Chia-Ling Chang; Yongjing Zhang; Junya Masuda; Grace Hui-Min Wu; Bryan Wahking; Shinichi Imafuku; Hong Qiu
deleteShare
deleteSave
Prevalence of Genital Psoriasis and Its Impact on Patients’ Sexual Life in Routine Care: Epidemiologic Survey in Germany
delete2026-01-21
delete0
deleteOAAI
deleteToni Maria Janke; Christina Sorbe; Rachel Sommer; Thomas Bickert; Ulrich Mrowietz; Susana Gomis-Kleindienst; Marius Schild; Kristina Lohmann; Matthias Augustin
deleteShare
deleteSave
Bidirectional Associations Between Substance Abuse and Psoriasis: A Prospective Cohort Study
delete2026-01-07
delete0
deleteOAAI
deleteXuanlin Che; Jiatong Zhou; Anqi Wang; Jia Guo; Chengcheng Zhang; Yi Xiao
deleteShare
deleteSave
Real-World Experience of Guselkumab in the Elderly Population
delete2025-12-26
delete0
deleteOAAI
deleteZeno Fratton; Stefano Bighetti; Luca Bettolini; Vincenzo Maione; Mariateresa Rossi; Marina Venturini; Vanessa Mazzoletti; Enrico Zelin; Giuseppe Stinco; Enzo Errichetti
deleteShare
deleteSave
Global Trends and Future Predictions of Psoriasis Burden: Insights from the GBD 2021 Study
delete2025-12-24
delete0
deleteOAAI
deleteXiaoyu Gu; Xinquan Wang; Yang Bin; Ruzeng Xue; Guannan Zhu
deleteShare
deleteSave
Antibodies Targeting Gasdermin E as a Potential Therapeutic Option for Psoriasis – A Pilot Study on a Mouse Model
delete2025-12-18
delete0
deleteOAAI
deleteJulia Nowowiejska-Purpurowicz; Justyna M Hermanowicz; Dariusz Pawlak; Iwona Flisiak; Tomasz Lipinski
deleteShare
deleteSave
Neurofunctional Reversibility in Psoriasis Vulgaris After IL-17A Inhibition: A Resting-State fMRI and Neurocognitive Analysis
delete2025-10-31
delete0
deleteOAAI
deleteJiayun Liu, Huiping Fan, Rui Sun, Yunyan Pang, Xiaojin Li, Qingsong Ma, Chen Xu, Dong Zhang, Weiyuan Ma
deleteShare
deleteSave
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study
delete2025-10-17
delete0
deleteOAAI
deleteJiawen Chen; Zhixun Xiao; Xueting Zeng; Niu Xiang; Renwei Luo; Rongying Chen; Beiqi Lin; Hui Ke; Ting Gong; Chao Ji
deleteShare
deleteSave
Evaluating the Role of Disease Duration in Systemic Therapy Response Among Patients with Moderate-to-Severe Psoriasis
delete2025-10-13
delete0
deleteOAAI
deleteMin Dai; Yuxiong Jiang; Yujing Xi; Lezhen Xu; Dawei Huang; Yu Wang; Yifan Hu; Qian Yu; Yuling Shi
deleteShare
deleteSave